Psychiatr. pro Praxi, 2007; 8(6): 262-265

Psychopharmacological intervention in Adjustment disorders

MUDr. Jiřina Kosová
Psychiatrické centrum Praha, 3. LF UK, Praha

Since there are no results of controlled clinical studies in patients with adjustment disorders our decision about therapeutic approach is based primarily on psychopathology observations and medication is initiated in line with symptoms. Considering possible psychopharmacological interventions in the clinical practice, increasing use of antidepressants is evident with selective serotonin reuptake inhibitors (SSRI) are a preferred choice. In the following text some main information about adjustment disorders and the results of some pharmacological studies are discussed.

Keywords: adjustment disorders, pharmacologic interventions

Published: January 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kosová J. Psychopharmacological intervention in Adjustment disorders. Psychiatr. praxi. 2007;8(6):262-265.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994.
    2. Barsevick AM, Sweeney C, Haney E, Chung E. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum 2002; 29: 73-84. Go to original source... Go to PubMed...
    3. Blacker CVR, Clare AW. The prevalence and treatment of depression in general practice. Psychopharmacology 1988; 95: 14-17. Go to original source... Go to PubMed...
    4. Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatient with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacology 1997; 11(2): 127-132. Go to original source... Go to PubMed...
    5. Bronish T. Adjustment reactions: A long term prospective and retrospective follow-up of former patients in a crisis intervention ward. Acta Psychiatr Scand 1991; 84: 86-93. Go to original source... Go to PubMed...
    6. Casey P. Adult adjustment disorder: A review of its current diagnostic status.
    7. Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 1985; 320 (Suppl): 85-92. Go to original source... Go to PubMed...
    8. Despland JN, Monod L, Ferrero F. Clinical relevance of adjustment disorder in DSM-III-R and DSM-IV. Comprehensive Psychiatry 1995; 36: 454-460. Go to original source... Go to PubMed...
    9. De Wit S, Cremers L, Hirsch D, Zulian C, Clumeck N, Kormoss N. Efficacy and safety of trazodone versus clorazepate in the treatment of HIVpositive subjects with adjustment disorders: a pilot study. Journal of Internal Medicine and Research 1999; 27(5): 223-232. Go to original source...
    10. Dowrick C, Casey P, Dalgard O et al. Outcome of Depression International Network (ODIN): Background, methods and field trials. Br J Psychiatry 1998; 172: 359-363. Go to original source... Go to PubMed...
    11. Fisch MJ, Loehrer PJ, Kristeller J et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003; 21: 1937-1943. Go to original source... Go to PubMed...
    12. Greenberg WM, Rosenfeld DN, Ortega EA. Adjustment disorder as an admissions diagnosis. Am J Psychiatry 1995; 152: 459-461. Go to original source... Go to PubMed...
    13. Holland JC, Morrow GR, Schmale A et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 1991; 9(6): 1004-1011. Go to original source... Go to PubMed...
    14. Holland JC, Romano SJ, Heiligenstein JH et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998; 7(4): 291-300. Go to original source... Go to PubMed...
    15. Jones R, Yates WR, Williams S et al. Outcome for adjustment disorders with depressed mood: Comparison with other mood disorders. J Affect Disord 1999; Suppl 55(1): 55-61. Go to original source... Go to PubMed...
    16. Kaplan H, Sadock B. Synopsis of psychiatry: Behavioural sciences/clinical psychiatry, 8th Edition. Philadelphia: Lippincott, Williams and Wilkins, 1998.
    17. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32: 57-71. Go to original source... Go to PubMed...
    18. Morrow GR, Hickok JT, Roscoe JA et al. Differential effects of paroxetine on fatigue and depression: a randomized double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Program. J Clin Oncol 2003; 21: 4635-4641. Go to original source... Go to PubMed...
    19. Musselman DL, Lawson DH, Gumnick JF et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001; 344: 961-966. Go to original source... Go to PubMed...
    20. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 2001; 70(1): 1-10. Go to original source... Go to PubMed...
    21. Polyakova I, Knobler HY, Ambrumova A et al. Characteristics of suicidal attempts in major depression versus adjustment reactions. J Affect Disord 1998; 47: 159-167. Go to original source... Go to PubMed...
    22. Razavi D, Alliaire JF, Smith M et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996; 94: 205-210. Go to original source... Go to PubMed...
    23. Razavi D, Kormoss N, Collard A, Farvacques C, Delvaux N. Comparative study of efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patiens: a pilot study. Journal of Internal Medicine and Research 1999; 27(6): 264-272. Go to original source...
    24. Roscoe JA, Morrow GR, Hickok JT et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2005; 89: 243-249. Go to original source... Go to PubMed...
    25. Servant D, Graziani PL, Moyse D, Parquet PJ. Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in double-blind controlled study. (Traitement du trouble de l´adaptation avec anxiete: evluation de l´efficacite et de la tolerance de l´etifoxine par un essai en double aveugle contre produit de reference.) Encephale 1998; 24(6): 569-574. Go to PubMed...
    26. Sharpe M, Strong V, Allen K et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer 2004; 90(2): 310-313. Go to original source... Go to PubMed...
    27. Silvestone PH. Prevalence of psychiatric disorders in medical inpatients. J Nerv Ment Disord 1996; 184: 43-51. Go to original source... Go to PubMed...
    28. Snyder S, Strain JJ, Wolf D. Differentiating major depression from adjustment disorder with depressed mood in a medical setting. Gen Hosp Psychiatry 1990; 12: 159-165. Go to original source... Go to PubMed...
    29. Spalletta G, Troisi A, Saracco M et al. Symptom profile, axis II comorbidity and suicidal behavior in young males with DSM-III-R depressive illnesses. J Affect Disord 1996; 39: 141-148. Go to original source... Go to PubMed...
    30. Terranova R, Gilotta SM, Luca S. Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders. Arzneimittelforschung 1997; 47 (11A): 1325-1328. Go to PubMed...
    31. Uitterhoeve RJ, Vernooy M, Litjens M et al. Psychosocial interventions for patients with advanced cancer - a systematic review of the literature. Br J Cancer 2004; 91: 1050-1062. Go to original source... Go to PubMed...
    32. Van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 1996; 169: 440-443. Go to original source... Go to PubMed...
    33. Williams S, Dale J. Effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 2006; 94: 372-390. Go to original source... Go to PubMed...
    34. Zygmont M, Prigerson HG, Houck PR, Miller MD, Shear MK, Jacobs S, Reynolds CF. A post hoc comparison of paroxetine and nortriptyline for symptom soft traumatic grief. Journal of Clinical Psychiatry 1998; 59(5): 241-245. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.